Are medications that raise ACE2 levels truly detrimental or beneficial in COVID-19 patients in Qatar?
- Funded by Qatar National Research Fund
- Total publications:1 publications
Grant number: RRC-2-047
Grant search
Key facts
Disease
COVID-19Funder
Qatar National Research FundPrincipal Investigator
Saghir AkhtarResearch Location
QatarLead Research Institution
Qatar UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC